Sub-components of the drug delivery device

By designing a sealable section at the distal end of the drug delivery device housing and the insertion method of the drive assembly, the mechanical performance and assembly complexity of the device were solved, resulting in more robust packaging and a simplified assembly process.

CN117750989BActive Publication Date: 2026-11-10SHL MEDICAL AG
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202280050438.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-08-09
Filing Date
2022-08-03
Publication Date
2026-11-10
Estimated Expiration
2042-08-03

AI Technical Summary

Technical Problem

Existing drug delivery devices are inadequate in terms of robustness and mechanical performance, and the assembly process is complex.

Method used

A sub-component of a drug delivery device is designed, including a housing and a drive assembly. The housing has a sealable portion at its distal end, and the drive assembly is inserted through the proximal end of the housing and discharges the drug by applying an activation force to the drug container structure. The design of the housing increases mechanical strength and simplifies the assembly process.

Benefits of technology

It improves the mechanical strength and assembly efficiency of the drug delivery device, simplifies the assembly process, and enhances the stability and ease of use of the device.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117750989B_ABST
    Figure CN117750989B_ABST
Patent Text Reader

Abstract

A sub-assembly (100) of a drug delivery device (102) includes a housing (104) and a drive assembly (110). The housing (104) is configured to receive a drug container structure (250) from which a drug is discharged during use of the drug delivery device (102). The housing (104) has a proximal end (106) and a distal end (108). The drive assembly (110) includes a proximal end of the drive assembly (110). A plunger rod (124) at (120) is configured to apply an activation force to the drug container structure (250) upon activation for discharging a drug from the drug delivery device (102), wherein the proximal end (106) of the housing (104) includes an opening (112) and the distal end (108) includes a sealable portion (114), wherein a drive assembly (110) is insertable into the housing (104) at the proximal end (106) to form the subassembly (100).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This disclosure generally relates to a sub-component of a pharmaceutical delivery device for discharging pharmaceuticals from a pharmaceutical container structure. Background Technology

[0002] Medications are typically dispensed from a medication delivery device to a so-called dose delivery site, such as through the skin of a person requiring the medication. Therefore, a medication delivery device includes a medication container that holds the medication. The medication container is preferably arranged within a housing and is dispensed upon exposure to activation, such as from a drive assembly.

[0003] Currently, many different drug delivery devices exist, including various types of pen injectors, autoinjectors, and on-body devices. For example, the needle can be positioned directly on the drug container, with a so-called rigid needle guard placed on the needle to protect it from exposure. The drug container with the needle is arranged together with the activation mechanism within a housing configured for this type of configuration.

[0004] While many of these devices have achieved significant improvements in the management of numerous medical conditions, various limitations remain in current technology. Of particular importance are the robustness and mechanical performance of the drug delivery system. Furthermore, the assembly of the drug delivery system before its use is an issue requiring further improvement. In light of these issues, the applicant has recognized that various developments can be undertaken to help improve drug delivery systems currently on the market, which will be elaborated in more detail below. Summary of the Invention

[0005] This invention is defined by the appended claims, and reference should now be made to the appended claims.

[0006] In this disclosure, when the term "distal direction" is used, it refers to a direction pointing away from the dose delivery site during use of the drug delivery device. When the term "distal portion / end" is used, it refers to the portion / end of the delivery device or its component located furthest from the dose delivery site during use of the drug delivery device. Correspondingly, when the term "proximal direction" is used, it refers to a direction pointing towards the dose delivery site during use of the drug delivery device. When the term "proximal portion / end" is used, it refers to the portion / end of the delivery device or its component located closest to the dose delivery site during use of the drug delivery device.

[0007] In addition, the terms “longitudinal,” “longitudinally,” “axially,” or “axial” refer to the direction from the proximal end to the distal end, typically extending along the longest extension direction of the device or its components.

[0008] Similarly, the terms "lateral," "transverse," and "laterally" refer to a direction that is approximately perpendicular to the longitudinal direction.

[0009] Furthermore, the terms "circumferential," "circumferential," or "circumferentially" refer to a circumferential or circumferential direction relative to an axis, which is typically a central axis extending in the longest extension direction of the device and / or component. Similarly, "radial" or "radiallyly" refers to a direction extending radially relative to an axis, and "rotational," "rotational," and "rotationally" refer to rotation relative to an axis.

[0010] According to a first aspect of this disclosure, a sub-assembly of a drug delivery device is provided, the sub-assembly including a housing and a drive assembly, the housing being configured to receive a drug container structure from which a drug is discharged during use of the drug delivery device, the housing having a proximal end and a distal end, the drive assembly including a plunger rod at the proximal end of the drive assembly, the plunger rod being configured to apply an activation force on the drug container structure upon activation to discharge the drug from the drug delivery device, wherein the proximal end of the housing includes an opening and the distal end includes a sealable portion, wherein the drive assembly is insertable into the housing at the proximal end to form the sub-assembly.

[0011] The drive component should be interpreted as a device configured to provide an activation force on the drug container structure during use of the drug delivery device. This activation force causes the drug to be expelled through the needle and into the dose delivery site. The activation force can be generated manually or automatically when the drug delivery device is pushed to the dose delivery site.

[0012] This disclosure is based on the insight that the mechanical strength of the housing can be increased by providing a sealable portion at the distal end of the housing. Therefore, one advantage is that it provides a more robust packaging housing for the pharmaceutical delivery device. In particular, the rear end of the housing has increased rigidity. Moreover, and as will be described in further detail below, the assembly process of components forming part of the sub-assemblies will be more efficient because all components are inserted from one side of the housing and from the same side (i.e., the proximal end of the housing). Since the housing is sealed at the distal end, there will also be no need to seal the housing as a final step in the assembly process.

[0013] According to an exemplary embodiment, the housing may include an envelope extending axially from a distal end to a proximal end, with a sealable portion integrally formed with the envelope. Thus, the sealable portion and the envelope are formed as a single unit.

[0014] According to an exemplary embodiment, the sealable portion may be formed of a removable cap. Therefore, the removable cap is attached to the distal end of the housing before the drive assembly is inserted into the housing. The removable cap can be attached to the distal end of the housing at the production site of the housing or at the assembly site of the assembled subassemblies.

[0015] According to an exemplary embodiment, when the drive assembly is inserted into the housing, the distal end of the drive assembly can be disposed at the distal end of the housing. Therefore, when disposed within the housing, the pharmaceutical container structure is disposed proximal to the drive assembly.

[0016] According to an exemplary embodiment, the housing may be a tubular housing, such as a cylindrical housing or a rectangular housing forming a hollow housing structure. Furthermore, according to an exemplary embodiment, the housing may include an inspection section.

[0017] The inspection section advantageously allows the user of the drug delivery device to visually inspect the drug currently present in the drug container structure. Therefore, the drug container structure is preferably formed of a transparent material or includes a reverse inspection hole aligned with the inspection section of the housing. To enable visual inspection of the drug container structure, the inspection section is preferably an elongated inspection section extending along the axial direction of the housing, wherein the proximal end of the inspection section is arranged closer to the proximal end of the housing than the distal end. Preferably, the elongated inspection section has an extension that allows the user of the drug delivery device to visually inspect the entire drug container structure. Therefore, the inspection section preferably has a length in the axial direction that is longer than the axial extension length of the drug container structure.

[0018] According to an exemplary embodiment, the sealable portion may include a connector portion on the surface facing the drive assembly. Therefore, the drive assembly can be attached to the connector portion, thereby preventing the drive assembly from falling out of the housing before final assembly is completed.

[0019] According to an exemplary embodiment, the housing may include a drive assembly guide structure extending axially on an inner surface of the housing. The drive assembly guide structure may be formed by, for example, one or more axially extending elongated tracks or equivalent structures on the inner surface of the housing. Such equivalent structures may be, for example, axially elongated grooves or axially extending protrusions in the housing. The guide structure simplifies the insertion of the drive assembly into the housing and ensures that the drive assembly is correctly inserted. In this exemplary embodiment, the drive assembly may preferably include means compatible with the drive assembly guide structure, such as notches or protrusions that slide along the tracks during insertion.

[0020] According to an exemplary embodiment, the drive assembly may include a biasing member connected to the plunger rod. Preferably, and according to an exemplary embodiment, the biasing member may be arranged to generate an activating force on the plunger rod. Thereby, the biasing member forces the plunger rod to expel the medication to the dosage delivery site. Preferably, and according to an exemplary embodiment, the biasing member may be a spring. The spring may preferably be a helical spring that generates an activating force in the axial direction of the medication delivery device.

[0021] According to a second aspect, a method for assembling a sub-assembly of a drug delivery device is provided, wherein the sub-assembly includes a housing and a drive assembly, the housing being configured to receive a drug container structure from which a drug is discharged during use of the drug delivery device, the housing having a proximal end and a sealed distal end, and the drive assembly being configured to generate an activation force on the drug container structure for discharging the drug when the drug container structure is arranged in the drug delivery device, the method comprising the steps of: inserting the drive assembly into the housing through an opening at the proximal end of the housing, and moving the drive assembly within the housing in a distal direction toward the sealed distal end of the housing.

[0022] Therefore, a simple assembly method is provided, wherein only the proximal end of the housing is open for receiving a drive assembly to form a sub-assembly. The drive assembly is preferably moved in a distal direction until it is positioned near the sealed distal end of the housing. According to a non-limiting exemplary embodiment, the drive assembly may be moved in a distal direction until the distal end of the drive assembly is arranged to abut the inner surface of the sealed distal portion.

[0023] The other effects and characteristics of the second aspect are largely similar to those described above regarding the first aspect.

[0024] According to a third aspect, a method for assembling a drug delivery device is provided, the drug delivery device including a sub-assembly comprising a housing having a proximal end and a distal end, wherein the proximal end of the housing includes an opening and the distal end includes a sealable portion, the sub-assembly further including a drive assembly, and a drug container structure containing a drug, wherein the method includes the steps of assembling the sub-assembly as described above with respect to the second aspect, and inserting the drug container structure into the housing through the opening at the proximal end of the housing.

[0025] Thus, an assembly is provided comprising the sub-components described by the first and second aspects and the pharmaceutical container structure, wherein each of the sub-components and the pharmaceutical container structure is assembled through the proximal end of the housing.

[0026] According to an exemplary embodiment, the drug delivery device may further include a discharge member, wherein the step of inserting the drug container structure into the housing is preceded by a step of inserting the drug container structure into the discharge member by moving the drug container structure in a proximal direction relative to the discharge member, thereby forming a drug discharge device, wherein the drug container structure is inserted into the housing by inserting the drug discharge device into the housing through the proximal opening of the housing.

[0027] This provides an intermediate assembly step in which the drug container structure is inserted into the discharge member before the drug container structure and the discharge member (i.e., the drug discharge device) are inserted into the housing at the proximal end of the housing.

[0028] According to an exemplary embodiment, the method may further include the step of moving the dispensing device distally within the housing toward a sealed distal end of the housing. Preferably, the dispensing device is moved distally until the distal end of the dispensing container structure is near the plunger rod of the drive assembly, such that a gap exists between the distal end of the dispensing container structure and the plunger rod. According to an exemplary embodiment, the dispensing device may alternatively be moved distally until the distal end of the dispensing container structure abuts the plunger rod of the drive assembly.

[0029] The additional effects and characteristics of the third aspect are largely similar to those described above regarding the first and second aspects.

[0030] Generally, unless otherwise expressly defined herein, all terms used in the claims shall be interpreted according to their ordinary meaning in the art. Unless otherwise expressly stated, all references to “a / an / the component, device, part, apparatus, etc.” shall be openly interpreted as referring to at least one instance of the component, device, part, apparatus, etc. Attached Figure Description

[0031] Specific embodiments of the inventive concept will now be described by way of example with reference to the accompanying drawings, wherein:

[0032] Figure 1A This is a perspective view of a drug delivery device in an assembled configuration according to an exemplary embodiment;

[0033] Figure 1B yes Figure 1A Exploded view of the drug delivery device in the diagram;

[0034] Figure 2 This is an exploded view of components forming part of a drug delivery device according to another exemplary embodiment;

[0035] Figure 3 This is an exploded view of the driving component according to an exemplary embodiment;

[0036] Figure 4A This is a schematic diagram of a method for assembling sub-components of a drug delivery device according to an exemplary embodiment;

[0037] Figure 4B yes Figure 4A The flowchart depicting the method is shown in the image.

[0038] Figure 5A This is a schematic diagram of a method for assembling a drug delivery device according to an exemplary embodiment; and

[0039] Figure 5B yes Figure 5A The flowchart depicting the method is shown in the image. Detailed Implementation

[0040] The inventive concept will now be described more fully below with reference to the accompanying drawings, in which exemplary embodiments are illustrated. However, the inventive concept can be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided by way of example so that this disclosure will be thorough and complete, and will fully convey the scope of the inventive concept to those skilled in the art. Throughout the specification, the same reference numerals refer to the same elements.

[0041] refer to Figure 1A and Figure 1B It shows a configuration for use from a pharmaceutical container structure (in) Figure 2 An exemplary embodiment of the drug delivery device 102 for discharging drugs is shown in detail below. Figure 1A The drug delivery device 102 in its assembled configuration is shown, and Figure 1B The drug delivery device 102 is shown in an exploded view.

[0042] As can be seen, the drug delivery device 102 includes a housing 104 having a proximal end 106 and a distal end 108. The proximal end 106 of the housing 104 is the end portion of the housing 104 arranged to be closest to the dose delivery site during use of the drug delivery device 102, compared to the distal end 108. Therefore, as seen in the axial direction of the housing 104, the distal end 108 of the housing 104 is the end portion of the housing 104 arranged to be furthest from the dose delivery site during use of the drug delivery device 102.

[0043] from Figure 1B It can be seen that the housing 104 includes an opening 112 at the proximal end 106, while the distal end 108 of the housing 104 includes a sealable portion 114. According to... Figure 1A and 1B In the illustrated embodiment, the sealable portion 114 is formed by a removable cap 116. The removable cap 116 may be provided with an external thread (not shown) that engages with the internal thread of the housing 104, thereby forming a threaded connection between the removable cap 116 and the housing 104. Other alternatives are also conceivable, such as a snap-fit ​​connection or a press-fit connection between the removable cap 116 and the housing 104. These are briefly described below and... Figure 4A As shown, the sealable portion 114 can alternatively be integrally formed with the encapsulating surface 118 of the housing 104. For example... Figure 1B As shown, the envelope 118 extends axially from the proximal end 106 of the housing 104 to the distal end 108.

[0044] The drug delivery device 102 also includes a drive assembly 110. The drive assembly 110 has a proximal end 120 and a distal end 122. The drive assembly 110 and the housing 102 thus form a sub-assembly 100 of the drug delivery device 102. Reference will now be made to... Figure 3 The drive assembly 110, described in further detail, includes a plunger rod 124 at its proximal end 120. During use of the drug delivery device 102, the plunger rod 124 is configured to apply an activating force to the drug container structure to expel the drug.

[0045] Furthermore, the drug delivery device 102 includes a discharge member 126, a cartridge 128, and a cartridge cap 130. The cartridge 128 should be understood hereinafter as part of the drug delivery device 102 including a needle (not shown), which will be further described below. The cartridge 128 may preferably be formed by two or more interconnected components forming the cartridge 128. In particular, the cartridge 128 includes a proximal cartridge portion 133 and a distal cartridge portion 135, and the needle is arranged within the distal cartridge portion 135. The proximal cartridge portion 133 is removably connected to the distal cartridge portion 135. Furthermore, the cartridge 128 preferably includes a needle hub (not shown) arranged in the proximal cartridge portion 135. The needle hub is arranged to retain the needle. Additionally, the needle hub is movable relative to the distal cartridge portion 135 and is movable to penetrate the drug container structure (in) during use of the drug delivery device 102. Figure 2 (See detailed diagram). The cartridge cap 130 is a cap disposed at the proximal end 132 of the cartridge 128. Therefore, when attached to the cartridge 128, the cartridge cap 130 prevents the needle from being exposed. Furthermore, the cartridge cap 130 is connected to the proximal portion 133 of the cartridge. In one example, by rotating the cartridge cap 130 relative to the distal portion 135 of the cartridge about the needle, the cartridge cap 130 and the proximal portion 133 are removed from the distal portion 135 of the cartridge. Thus, the needle is exposed for use with the drug delivery device, i.e., for penetrating the needle at, for example, a dose delivery site. The discharge member 126 includes a needle cap 123 and a container holder 125. The discharge member 126, and in particular the container holder 125, is configured to receive a drug container structure, and the cartridge 128 is arranged to be connected to the discharge member 126. As described above, the cartridge 128 includes a needle (not shown) at a proximal end 132 of the cartridge, and a cartridge cap 130 is removably attached to the cartridge 128 at the proximal end 132 of the cartridge. Therefore, two types of drug container structures exist. Figure 1A and Figure 1B In the first exemplary embodiment shown, the needle is arranged in the cartridge 128 and positioned to penetrate the medication container structure before the use of the medication delivery device 102. Therefore, in Figure 1A and 1BIn the first embodiment shown, the needle does not form part of the drug container structure. In the second exemplary embodiment, which is described in further detail below, the needle alternatively forms part of the drug container structure.

[0046] When Figure 1A When assembling the drug delivery device 102 as shown, the drive assembly 110 and the discharge member 126 are arranged within the housing 104. The cartridge 128 is at least partially arranged within the housing 104, while the cartridge cap 130 is arranged outside the housing 104. Specifically, and as seen in the direction from the distal end 108 to the proximal end 106, the housing 104 houses the drive assembly 110, the discharge member 126, and the cartridge 128. Furthermore, as... Figure 1B As shown, the sealable portion 114 may include a connector portion 134 on the surface of the sealable portion 114 facing the drive assembly 110. Therefore, the drive assembly 110 can be attached to the sealable portion 114 at the connector portion 134.

[0047] refer to Figure 2 To describe the components of a drug delivery device 102 according to another exemplary embodiment. Although the above describes... Figure 1A and Figure 1B The described embodiments relate to a so-called cartridge construction, but Figure 2 The embodiments involve a so-called syringe construction. As described above, Figure 1A-1B The first exemplary embodiment and Figure 2 The difference between the two exemplary embodiments is that, in the first exemplary embodiment, the needle forms part of the cartridge 128, while in the second exemplary embodiment, the needle forms part of the drug container structure 250.

[0048] For example from the shell ( Figure 2 Seen at the distal end (not shown in the image). Figure 2 The exemplary embodiment of the drug delivery device 102 depicted includes the aforementioned container holder 125, a drug container structure 250 containing the drug, a needle cap 123, a rigid needle guard 131, and a guard remover 129. In a manner similar to that described above regarding the cartridge construction, the needle cap 123 and the container holder 125 form part of the discharge member 126. Figure 2 In the second exemplary embodiment depicted, and as indicated above, the medicine container structure 250 includes a needle 252 at its proximal end. Therefore, the needle 252 is disposed on the medicine container structure 250 prior to use.

[0049] Therefore, the medication container structure 250 includes a needle 252. The needle 252 is disposed within a rigid needle guard 131 before use. The rigid needle guard 131 is an axially extending portion arranged to embed the needle 252 and protect it from external damage. The rigid needle guard 131 is, in turn, housed within a guard remover 129. Furthermore, viewed radially from the medication delivery device 102, the medication container structure 250 is disposed within a container holder 125, and a needle cap 123 is disposed outside the container holder 125. Although not in... Figure 2 The description is incomplete, but the drug container structure 250, container holder 125, and needle cap 123 are all arranged in an assembled configuration similar to... Figure 1A and 1B Inside the shell 104 depicted in the image. Furthermore... Figure 2 The arrangement also preferably includes a needle cap (not shown) that houses the rigid needle guard 131 before use. The needle cap is preferably also attached to the needle cover at its proximal end and is removed before use of the drug delivery device 102.

[0050] Before using the drug delivery device 102, remove the needle cap (not shown). When the needle cap is removed, the shroud remover 129 is also removed, forcing the rigid needle shroud 131 to be pulled away from the needle 252, thereby exposing the needle 252. Refer to the following... Figure 3 An exemplary embodiment of how the drug delivery device 102 is prepared for use is given.

[0051] Figure 2 The second embodiment depicted in the text is similar to Figure 1A and 1B The difference between the first embodiment depicted is that, in the second exemplary embodiment, the needle 252 is arranged on the pharmaceutical container structure 250. Figure 1A and Figure 1B In the first exemplary embodiment shown, the needle is alternatively formed as part of the cartridge 128. Therefore, Figure 1A and Figure 1B The first embodiment includes a drug container structure to which no needle is attached. Instead, the needle in the cartridge 128 penetrates the drug container structure during use of the drug delivery device 102.

[0052] For a more detailed description of driver component 110, please refer to [reference needed]. Figure 3 , Figure 3 This is an exploded view of the driving component 110 according to an exemplary embodiment. It should be readily understood that... Figure 3 The features of the drive component 110 described herein are for illustration and description only of contemplated embodiments of the drive component 110. The drive component 110 can be arranged in a variety of different configurations, and... Figure 3 Compared to other embodiments, it has more or fewer components.

[0053] according to Figure 3An embodiment of the drive assembly 110 includes the aforementioned plunger rod 124 at its proximal end 120. The drive assembly 110 also includes a slider element 202, a drive assembly frame structure 204, a plunger rod guide member 206, and a biasing member 208. Figure 3 As shown, the biasing member 208 is preferably a spring arranged in the form of a helical spring. The drive assembly 110 also includes an end-click member 210, a sleeve 212, an activation spring 214, an start-click member 216, a frame cover 218, and a clamping plate 220.

[0054] The function of the drive assembly 110 will be briefly described below. Therefore, a detailed description of the interactions between all components of the drive assembly will not be given. Since the drive assembly can be arranged in many different configurations, only the overall function will be provided. When the drug delivery device 102 is positioned from the starting position (i.e., before the cartridge cap 130 is removed from the cartridge 128) to the injection position (i.e., when the cartridge cap 130 is removed from the cartridge 128), the sleeve 212 moves in the distal direction along the drive assembly frame structure 204, which remains stationary relative to the sleeve 212. According to one example, the proximal end of the sleeve 212 is positioned as follows, for example... Figure 1A The drug delivery device 102 depicted is arranged in an assembly configuration abutting the distal end of the needle cap 123. Therefore, when the user applies an axial force that moves the needle cap 123 axially relative to the drive assembly frame structure 204, the sleeve 212 moves in the distal direction. An activation spring 214 is arranged abutting the sleeve 212 and the start-click member 216. The sleeve 212 interacts with the activation spring, and by moving the sleeve 212 in the distal direction, the activation spring 214 is compressed, and the start-click member 216 is also moved slightly distally. The activation spring 214 is compressed until the start-click member 216 is positioned at its end near the distal end 122 of the drive assembly 110. The drug delivery device 102 is now ready to inject the drug into the dosage delivery site. Subsequently, when the medication is to be discharged from the medication container structure, the drive assembly 110 is activated, thereby causing the biasing member 208 to push the plunger rod 124 against the medication container structure, thus generating an activation force on the medication container structure. This activation force forces the medication to be discharged from the medication container structure and expelled through the needle.

[0055] The following will describe the above regarding Figure 1A-1B and Figure 2 The method for assembling sub-component 100 is described. Therefore, refer to... Figure 4A and 4B ,in Figure 4A This is a schematic diagram of a method for assembling a sub-component 100 of a drug delivery device 102 according to an exemplary embodiment, and Figure 4B This is a flowchart of an exemplary method. (For...) Figure 4Aand 4B And targeting Figure 5A and 5B The description is about the above. Figure 2 The syringe construction is described herein. However, it should be readily understood that the following disclosure also applies to the above description of the syringe. Figure 1A and Figure 1B The described cartridge structure.

[0056] As in Figure 4A As can be seen in the embodiments, the housing 104 also includes an elongated inspection portion 302. The elongated inspection portion 302 is arranged near the proximal end 106 of the housing 104. More specifically, the proximal end 304 of the inspection portion 302 is arranged closer to the proximal end 106 of the housing than to the distance to the distal end 108 of the housing 104. Also as Figure 4A As shown and as described above, the sealable portion 114 is integrally formed with the envelope surface 118 of the housing 104. Therefore, the sealable portion 114 and the envelope surface 118 are formed integrally. Furthermore, Figure 4A The embodiment also includes a drive assembly guide structure 308 on the inner surface of the housing 104. Figure 4A In an exemplary embodiment, the drive component guide structure 308 is arranged as an elongated trace extending between the proximal end 106 and the distal end 108 within the housing 104.

[0057] During the assembly of subassembly 100, drive assembly 110 is inserted S1 into opening 112 disposed at the proximal end 106 of housing 104. Specifically, drive assembly 110 is inserted into opening 112 by inserting the distal end 122 of drive assembly 110 into opening 112. Thereafter, drive assembly 110 is moved S2 within housing 104 in the distal direction toward the distal end 108 of housing 104. Thus, when assembling subassembly 100, drive assembly is disposed distal to the distal end 306 of inspection portion 302, as can be seen in the assembly configuration depicted within box 320. According to a non-limiting example, drive assembly may be moved within housing 104 until the distal end 122 of drive assembly abuts the inner surface of sealable portion 114.

[0058] Therefore, sub-component 100 can be transported together with discharge component 126 to, for example, another production site or the end user of pharmaceutical delivery device 102. Thus, the assembled sub-component 100 is preferably not connected to discharge component 126 at this stage.

[0059] refer to Figure 5A and 5B This describes the method of assembling the drug delivery device 102. More specifically, Figure 5A This is a schematic diagram of a method for assembling a drug delivery device 102 according to an exemplary embodiment, and Figure 5B yes Figure 5A The flowchart depicting the method is shown in the image.

[0060] As an initial step, based on the above regarding Figure 4A and 4B The S11 sub-assembly is assembled in the manner described. Therefore, the drive assembly 110 is inserted through the opening 112 at the proximal end 106 of the housing to form the sub-assembly 100. The drug container structure 250 is then inserted into the S12 housing 104 through the opening 112 at the proximal end 106 of the housing 104.

[0061] Preferably, and as Figure 5A As depicted, before inserting the medicine container structure 250 into the housing 104, the medicine container structure 250 is inserted into the discharge member 126 in step S11'. Specifically, the medicine container structure 250 is inserted into the discharge member 126 by moving it proximally relative to the discharge member 126. The medicine container structure 250 and the discharge member 126 thus form a medicine discharge device 330. Step S12, inserting the medicine container structure 250 into the housing 104 at the opening 112 at the proximal end 106, is thus performed by moving the medicine discharge device 330 into the housing 104 through the opening 112 at the proximal end 106 of the housing 104.

[0062] Subsequently, the drug dispensing arrangement 330 and thus the drug container structure 250 move distally within the housing 104 until the final assembly position is reached. Preferably, the assembly position is reached when the drug container structure abuts against the plunger rod 124 of the drive assembly 110, or when the drug container structure is arranged near the plunger rod 124 of the drive assembly 110. According to another example, the device may include the aforementioned cartridge cap 130, whereby the final assembly position is reached when the cartridge cap 130 abuts against the proximal end 106 of the housing 104.

[0063] When the drug delivery device 102 is finally assembled, the drug container structure 250 will be arranged at the inspection section 302 of the housing 104 so that the user of the drug delivery device can perform an inspection.

[0064] According to some variations, instead of the aforementioned automatic spring-loaded structure, the drive assembly can be, for example, motor-driven or manually driven. Furthermore, it is envisioned that the medicine container structure 250 can be inserted into the housing 104 instead of being arranged within the discharge member 126. For example, in use Figure 1A and 1B In the case of the cartridge configuration depicted, the cartridge 128 can be directly inserted into the housing 104 together with the drug container structure 250 without using the discharge member 126. In this case, the cartridge can be supported, for example, by the inner frame of the housing or by a portion of the cartridge cap 130.

[0065] The inventive concept has been described above primarily with reference to several examples. However, as will be readily understood by those skilled in the art, other embodiments besides those disclosed above are also possible within the scope of the inventive concept as defined by the appended claims.

Claims

1. A sub-assembly (100) of a drug delivery device (102), the sub-assembly comprising: A housing (104) configured to house a pharmaceutical container structure from which pharmaceuticals are discharged during use of the pharmaceutical delivery device, the housing (104) having a proximal end (106) and a distal end (108), and A drive assembly (110) includes a plunger rod at its proximal end (120), the plunger rod being configured to apply an activation force on the drug container structure upon activation for discharging the drug from the drug delivery device. The proximal end (106) of the housing (104) includes an opening (112), and the distal end (108) includes a sealable portion (114), wherein the drive assembly (110) is capable of being inserted into the housing (104) at the proximal end (106) to form the subassembly (100). The housing (104) includes an envelope (118) extending axially from the distal end (106) to the proximal end (108), and the sealable portion (114) is integrally formed with the envelope (118).

2. The sub-component (100) according to claim 1, wherein when the drive assembly (110) is inserted into the housing (104), the distal end (122) of the drive assembly (110) is disposed at the distal end (106) of the housing (104).

3. The sub-component (100) according to claim 1 or 2, wherein the housing (104) is a cylindrical housing forming a hollow housing structure.

4. The sub-assembly (100) according to claim 1 or 2, wherein the housing (104) includes an inspection portion (302).

5. The sub-assembly (100) according to claim 4, wherein the inspection portion (302) is an elongated inspection portion extending along the axial direction of the housing (104), wherein the proximal end (304) of the inspection portion (302) is arranged to be closer to the proximal end (106) of the housing (104) than the distal end (108) of the housing (104).

6. The sub-assembly (100) according to claim 1 or 2, wherein the sealable portion (114) includes a connector portion (134) on the surface facing the drive assembly (110).

7. The sub-assembly (100) according to claim 1 or 2, wherein the housing (104) includes a drive assembly guide structure (308) extending axially on the inner surface of the housing.

8. The sub-assembly (100) according to claim 1 or 2, wherein the drive assembly (110) includes a biasing member (208) connected to the plunger rod (124).

9. The sub-assembly according to claim 8, wherein the biasing member (208) is arranged to generate the activation force on the plunger rod (124).

10. A method of assembling a sub-assembly (100) of a drug delivery device (102), wherein the sub-assembly (100) includes a housing (104) and a drive assembly (110), the housing (104) being configured to receive a drug container structure (250) from which a drug is discharged during use of the drug delivery device (102), the housing (104) having a proximal end (106) and a sealed distal end (108), the drive assembly (110) being configured to generate an activating force on the drug container structure (250) for discharging the drug when the drug container structure (250) is arranged in the drug delivery device (102), the method comprising the steps of: The drive assembly (110) is inserted (S1) into the housing (104) through the opening (112) at the proximal end (106) of the housing (104), and The drive assembly (110) is moved in the distal direction toward the sealed distal end (108) of the housing (104) within the housing (104) (S2).

11. A method of assembling a pharmaceutical delivery device (102), said pharmaceutical delivery device (102) comprising a sub-component (100) according to any one of claims 1-9 and a pharmaceutical container structure (250) containing a pharmaceutical agent, The method includes the following steps: The drive assembly (110) is inserted (S1) into the housing (104) through the opening (112) at the proximal end (106) of the housing (104), and the drive assembly (110) is moved (S2) within the housing (104) in the distal direction toward the sealed distal end (108) of the housing (104) to assemble (S11) the sub-assembly (100), and After the sub-component (100) is assembled, the medicine container structure (250) is inserted (S12) into the housing (104) through the opening (112) at the proximal end (106) of the housing (104).

12. The method of claim 11, wherein the drug delivery device (102) further comprises a discharge member (126), wherein the steps preceding the step of inserting the drug container structure (250) into the housing (104) are: By moving the drug container structure (250) in the proximal direction relative to the discharge member (126), the drug container structure (250) is inserted (S11') into the discharge member (126), thereby forming a drug discharge device (330). The drug container structure (250) is inserted into the housing (104) by inserting the drug dispensing device (330) into the housing (104) through the opening (112) at the proximal end (106).

13. The method of claim 12, further comprising the step of: The drug dispensing device (330) is moved in the distal direction within the housing (104) toward the sealed distal end (108) of the housing (104).

Citation Information

Patent Citations

  • An autoinjector that mixes wet and dry medicament components when moved relative to its packaging

    GB2447787A

  • Medication administering device

    US20110004165A1

  • Automatic reconstitution for dual chamber syringe

    US9821118B2